Search
SOLACI Congress
HomeTCT 2019highlights

highlights

      View Category
      highlights

      TCT 2019 | SCOPE I: Self-Expanding Valve Acurate Neo Head to Head with Sapien 3

      Courtesy of SBHCI. This work, which was presented during the TCT 2019 Scientific Sessions and simultaneously published in...
      solaci -
      Learn More
      Antiplatelet

      TCT 2019 | MODEL U-SES: More Devices for High Risk of Bleeding and Short DAPT

      Courtesy of SBHCI. This study tested the safety of dual antiplatelet therapy (DAPT) after only three months of...
      solaci -
      Learn More
      Antiplatelet

      TCT 2019 | EVOLVE Short DAPT: Only 3-month DATP in High Risk Bleeding

      Courtesy of the SBHCI. This study used the thin strut everolimus eluting stent with ultrathin abluminal bioresorbable polymer...
      solaci -
      Learn More
      Antiplatelet

      TCT 2019 | AUGUSTUS ACS: Apixaban vs. Warfarin and Aspirin vs. Placebo in AF and ACS

      Courtesy of SBHCI. The safety and efficacy of antithrombotic and antiplatelet treatments in patients with atrial fibrillation...
      solaci -
      Learn More
      Coronary disease

      TCT 2019 | IDEAL-LM: Bioabsorbable Polymer DES vs. Permanent Polymer DES for Left Main Stenosis

      Courtesy of SBHCI. This study showed that using the everolimus eluting stent with bioabsorbable polymer Synergy followed by...
      solaci -
      Learn More
      Coronary disease

      TCT 2019 | Onyx ONE: Durable Polymer vs. Polymer-Free Stent with Only One Month of Dual Antiplatelet Therapy

      Courtesy of the SBHCI. This is the first randomized study comparing a durable-polymer drug-eluting stent (zotarolimus-eluting stent Onyx)...
      solaci -
      Learn More
      Antiplatelet

      TCT 2019 | TWILIGHT: Minimal DAPT in High Bleeding Risk Patients

      Courtesy of the SBHCI. Monotherapy with a P2Y12 inhibitor after a minimum period (3 months) of dual antiplatelet...
      solaci -
      Learn More

      SOLACI is the reference organization for Latin American cardiovascular interventionism.

      Last News

      Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

      Dr. Omar Tupayachi - 0
      Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Institutional News

      Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

      Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

      solaci - 0
      Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

      25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

      Access

      Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy